(Icelandic: Íslensk erfðagreining) is a biopharmaceutical company based in Reykjavík, Iceland.
Emergent BioSolutions, a multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
In the private sector, Osborn has been a senior executive for several prominent firms in life sciences and healthcare, including biopharmaceutical companies Cephalon, Dendreon and Onyx Pharmaceuticals, and the cancer services company US Oncology, Inc. (which now operates as part of McKesson Specialty Health, a unit of McKesson Corporation).
Advised Johnson & Johnson on its bid for all ordinary shares of the biopharmaceutical company Crucell N.V..
Neuroaid (also NeuroAiD, MLC 601, or MLC 901) is a claimed treatment for stroke sold by Moleac Pte Ltd, a biopharmaceutical company in Singapore.
In 2010, Stallergenes signed an exclusive partnership agreement with Japanese biopharmaceutical company Shionogi & Co., Ltd. to promote the development, registration, and distribution of the "Stalair Program" in Japan.